1 |
Noguchi JK, Gill MA. Sulbactam: a beta-lactamase inhibitor. Clin Pharm 1988; 7: 37-51
|
2 |
Piddock LJ. Does the use of antimicrobial agents in veterinary medicine and animal husbandry select antibiotic-resistant bacteria that infect man and compromise antimicrobial chemotherapy? J Antimicrob Chemother 1996; 38: 1-3
DOI
ScienceOn
|
3 |
Gentilini E, Denamiel G, Llorente P, Godaly S, Rebuelto M, DeGregorio O. Antimicrobial susceptibility of Staphylococcus aureus isolated from bovine mastitis in Argentina. J Dairy Sci 2000; 83: 1224-1227
DOI
ScienceOn
|
4 |
Kerro Dego O, van Dijk JE, Nederbragt H. Factors involved in the early pathogenesis of bovine Staphylococcus aureus mastitis with emphasis on bacterial adhesion and invasion. A review. Vet Q 2002; 24: 181-198
DOI
ScienceOn
|
5 |
National Mastitis Council. Laboratory Handbook on Bovine Mastitis. Arlington: Natiotional Mastitis Council, Inc. 1999: 11-108
|
6 |
Makovec JA, Ruegg PL. Antimicrobial resistance of bacteria isolated from dairy cow milk samples submitted for bacterial culture: 8,905 samples (1994-2001). J Am Vet Med Assoc 2003; 222: 1582-1589
DOI
ScienceOn
|
7 |
Mealey KL. Penicillins and beta-lactamase inhibitor combinations. J Am Vet Med Assoc. 2001; 218: 1893-1896
DOI
ScienceOn
|
8 |
Mitchell JM, Griffiths MW, McEwen SA, McNab WB, Yee AJ. Antimicrobial drug residues in milk and meat: causes, concerns, prevalence, regulations, tests, and test performance. J Food Prot 1998; 61: 742-756
DOI
|
9 |
Williams JD. Beta-lactamases and beta-lactamase inhibitors. Int J Antimicrob Agents 1999; 12: S3-S7
|
10 |
Kim WJ, Park SC. Bacterial resistance to antimicrobial agents: an overview from Korea. Yonsei Med J 1998; 39: 488-494
DOI
|
11 |
Schwiersch U, Lang N, Wildfeuer DA. Concentration of sulbactam and ampicillin in serum and the myometrium. Drugs 1986; 31: 26-28
DOI
ScienceOn
|
12 |
Akalin HE. The role of beta-lactam/beta-lactamase inhibitors in the management of mixed infections. Int J Antimicrob Agents 1999; 12: S15-S20
DOI
|
13 |
Gentilini E, Denamiel G, Betancor A, Rebuelto M, Rodriguez Fermepin M, De Torrest RA. Antimicrobial susceptibility of coagulase-negative staphylococci isolated from bovine mastitis in Argentina. J Dairy Sci 2002; 85: 1913-1917
DOI
ScienceOn
|
14 |
Hashisaki PA, Jacobson JA. Characteristics, control, and treatment of methicillin-resistant Staphylococcus aureus infections. Clin Pharm 1982; 1: 343-348
|
15 |
Guinane CM, Sturdevant DE, Herron-Olson L, Otto M, Smyth DS, Villaruz AE, Kapur V, Hartigan PJ, Smyth CJ, Fitzgerald JR. Pathogenomic analysis of the common bovine Staphylococcus aureus clone (ET3): emergence of a virulent subtype with potential risk to public health. J Infect Dis. 2008; 197: 205-213
DOI
ScienceOn
|
16 |
Kwon NH, Park KT, Jung WK, Youn HY, Lee Y, Kim SH, Bae W, Lim JY, Kim JY, Kim JM, Hong SK, Park YH. Characteristics of methicillin resistant Staphylococcus aureus isolated from chicken meat and hospitalized dogs in Korea and their epidemiological relatedness. Vet Microbiol 2006; 117: 304-312
DOI
|
17 |
Zhang YL, Li JT. The in vitro activity of sulbactam combined with third generation cephalosporins against third generation cephalosporin-resistant bacteria. Int J Antimicrob Agents 2001; 17: 143-146
DOI
ScienceOn
|
18 |
Finegold SM. In vitro efficacy of beta-lactam/beta-lactamase inhibitor combinations against bacteria involved in mixed infections. Int J Antimicrob Agents 1999; 12: S9-S14
DOI
ScienceOn
|
19 |
Erskine R, Cullor J, Schaellibaum M, Yancey B, Zecconi A. Bovine mastitis pathogens and trends in resistance to antibacterial drugs. National Mastitis Council Proceedings 2004; 400-413
|
20 |
Shryock TR, Apley M, Jones RN , Lein DH, Thornsberry C, Walker RD, Watts JL, White DG, Wu CC. Performance Standards for Antimicrobial disk and Dilution Susceptibility Tests for Bacteria isolated from Animals; NCCLS M31-A2, 2nd ed. Pennsylvania: National Committee for Clinical laboratory Standards. 2002: 13-30
|
21 |
Hirano L, Bayer AS. Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci. Antimicrob Agents Chemother 1991; 35: 685-690
DOI
ScienceOn
|
22 |
McDougal LK, Thornsberry C. New recommendations for disk diffusion antimicrobial susceptibility tests for methicillinresistant (heteroresistant) staphylococci. J Clin Microbiol 1984; 19: 482-488
|
23 |
Kazmierczak A, Duez JM, Pechinot A, Nordmann P, Labia R. In vitro bactericidal activity of sulbactam plus ampicillin against methicillin-resistant Staphylococcus aureus. Rev Infect Dis 1986; 8: S549-S554
DOI
|
24 |
Warnke JP, Wildfeuer A, Eibel G, Pfaff G, Klammer A. Pharmacokinetics of ampicillin/sulbactam in patients undergoing spinal microneurosurgical procedures. Int J Clin Pharmacol Ther 1998; 36: 253-257
|
25 |
Williams JD. Beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone. Clin Infect Dis 1997; 24: 494-497
DOI
ScienceOn
|
26 |
Juhasz-Kaszanyitzky E, Janosi S, Somogyi P, Dan A, van der Graaf-van Bloois L, van Duijkeren E, Wagenaar JA. MRSA transmission between cows and humans. Emerg Infect Dis 2007; 13: 630-632
DOI
ScienceOn
|
27 |
Pak SI, Han HR, Shimizu A. Characterization of methicillinresistant Staphylococcus aureus isolated from dogs in Korea. J Vet Med Sci 1999; 61: 1013-1018
DOI
ScienceOn
|
28 |
Randhawa B, Harris EB, Prabhakaran K. Bactericidal action of oral ampicillin/sulbactam against Mycobacterium leprae. J Antimicrob Chemother 1999; 44: 279-281
DOI
|
29 |
Dajani A. Use of ampicillin/sulbactam and sultamicillin in pediatric infections: a re-evaluation. J Int Med Res 2001; 29: 257-269
DOI
ScienceOn
|
30 |
Moon JS, Lee AR, Kang HM, Lee ES, Kim MN, Paik YH, Park YH, Joo YS, Koo HC. Phenotypic and genetic antibiogram of methicillin-resistant staphylococci isolated from bovine mastitis in Korea. J Dairy Sci 2007; 90: 1176-1185
DOI
ScienceOn
|
31 |
Retsema JA, English AR, Girard A, Lynch JE, Anderson M, Brennan L, Cimochowski C, Faiella J, Norcia W, Sawyer P. Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection. Rev Infect Dis 1986; 8: S528-S534
DOI
|
32 |
Wexler HM, Harris B, Carter WT, Finegold SM. In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria. Antimicrob Agents Chemother 1985; 27: 876-878
DOI
ScienceOn
|
33 |
Janosi S, Huszenicza A, Horvath T, Gemes F, Kulcsar M, Huszenicza G. Bacteriological recovery after intramuscular or intracisternal spiramycin-based drying-off therapy. Acta Vet Hung 2001; 49: 155-162
DOI
ScienceOn
|
34 |
Erskine RJ, Walker RD, Bolin CA, Bartlett PC, White DG. Trends in antibacterial susceptibility of mastitis pathogens during a seven-year period. J Dairy Sci 2002; 85: 1111-1118
DOI
ScienceOn
|